Kamal Albarazanji - Concepedia

Author

Kamal Albarazanji

Also Known As

K A Al‐Barazanji, K al‐Barazanji, K. A. Al-Barazanji, K. A. Al‐Barazanji, K.A. Al-Barazanji, KAMAL A AL-BARAZANJI, KAMAL A. ALBARAZANJI, Kamal A Al-Barazanji, Kamal A. Al-Barazanji, Kamal A. Albarazanji

Publications

884

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Molecular Discovery (United Kingdom)GlaxoSmithKline (United Kingdom)Janssen (United States)

About

Kamal Albarazanji is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	588
2	Health Sciences	3	3	266
3	Public Health	1	1	23
4	Social Sciences	1	1	138
5	Allergy	1	1	34

Kamal Albarazanji

Publications

857

Citations

H-Index

Page 1

	Year	Citations
Central Exendin‐4 Infusion Reduces Body Weight without Altering Plasma Leptin in (<i>fa/fa</i>) Zucker Rats Kamal Albarazanji, Jonathan R.S. Arch, Robin E. Buckingham, Obesity Research	2000	210
Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats Robin E. Buckingham, Kamal Albarazanji, C. D. N. Toseland, Diabetes HypertensionZucker RatsInsulin SignalingOxidative StressMetabolic Syndrome	1998	205
Central Orexin‐A Activates Hypothalamic‐Pituitary‐Adrenal Axis and Stimulates Hypothalamic Corticotropin Releasing Factor and Arginine Vasopressin Neurones in Conscious Rats Kamal Albarazanji, Shelagh Wilson, Jennifer R. Baker, Journal of Neuroendocrinology Synaptic TransmissionArginine Vasopressin NeuronesAvp ExpressionHypothalamic CircuitsSocial Sciences	2001	138
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham, Bioorganic & Medicinal Chemistry Letters MedicineRational Drug DesignMechanism Of ActionChemical BiologyPharmacology	2006	47
Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1 Francis X. Tavares, Kamal Albarazanji, Eric C. Bigham, Journal of Medicinal Chemistry Mch Ko MicePharmacotherapyGastrointestinal Peptide HormoneMetabolic SyndromeHypothalamic Peptide	2006	34
Orexin Expression and Function: Glucocorticoid Manipulation, Stress, and Feeding Studies Gemma K. Ford, Kamal Albarazanji, Shelagh Wilson, Endocrinology Emulsion GrainsMammalian PhysiologyGlucocorticoidPrepro-orexin MrnaOxidative Stress	2005	34
Effects of Intracerebroventricular Infusion of Leptin in Obese Zucker Rats Kamal Albarazanji, Robin E. Buckingham, Jonathan R.S. Arch, Obesity Research Food IntakeInsulin SignalingGastrointestinal Peptide HormoneObesityMetabolic Syndrome	1997	27
Novel benzimidazole-based MCH R1 antagonists Andrew J. Carpenter, Kamal Albarazanji, Kevin K. Barvian, Bioorganic & Medicinal Chemistry Letters MedicineRational Drug DesignPharmacological AgentPharmacotherapyPharmacology	2006	26
Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits Weimei Sun, Xuqing Zhang, Maxwell D. Cummings, Journal of Pharmacology and Experimental Therapeutics	2020	26
C-Terminal Fragments of ACTH Stimulate Feeding in Fasted Rats Kamal Albarazanji, Jacqueline E. Miller, Suman Rice, Hormone and Metabolic Research Animal PhysiologyNutritionActh 18-39NeuropeptidesBiochemistry	2001	23

Page 1